AbbVie Stock Performance

<div class='circular--portrait' style='background:#CD0D74;color: white;font-size:3em;padding-top: 40px;;'>ABB</div>
ABBV -- USA Stock  

Fiscal Quarter End: March 31, 2020  

AbbVie has performance score of 1 on a scale of 0 to 100. The firm shows Beta (market volatility) of 0.024, which signifies that as returns on market increase, AbbVie returns are expected to increase less than the market. However during bear market, the loss on holding AbbVie will be expected to be smaller as well. Although it is extremely important to respect AbbVie historical returns, it is better to be realistic regarding the information on equity current trending patterns. The philosophy in foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By analyzing AbbVie technical indicators you can presently evaluate if the expected return of 0.0325% will be sustainable into the future. AbbVie right now shows a risk of 1.52%. Please confirm AbbVie Coefficient Of Variation, Semi Variance, Price Action Indicator, as well as the relationship between Treynor Ratio and Daily Balance Of Power to decide if AbbVie will be following its price patterns.

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in AbbVie are ranked lower than 1 (%) of all global equities and portfolios over the last 30 days. Inspite fairly stable primary indicators, AbbVie is not utilizing all of its potentials. The prevailing stock price fuss, may contribute to near short-term losses for the directors.
Fifty Two Week Low62.66
Target High Price130.00
Fifty Two Week High97.86
Payout Ratio81.06%
Trailing Annual Dividend Yield4.66%
Target Low Price84.00

AbbVie Relative Risk vs. Return Landscape

If you would invest  8,833  in AbbVie on January 26, 2020 and sell it today you would earn a total of  117.00  from holding AbbVie or generate 1.32% return on investment over 30 days. AbbVie is currently generating 0.0325% of daily expected returns and assumes 1.5228% risk (volatility on return distribution) over the 30 days horizon. In different words, 13% of equities are less volatile than AbbVie and 99% of traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.
 Daily Expected Return (%) 
  Risk (%) 
Given the investment horizon of 30 days, AbbVie is expected to generate 1.5 times more return on investment than the market. However, the company is 1.5 times more volatile than its market benchmark. It trades about 0.02 of its potential returns per unit of risk. The DOW is currently generating roughly -0.06 per unit of risk.

AbbVie Market Risk Analysis

Sharpe Ratio = 0.0214
Good Returns
Average Returns
Small Returns
Negative ReturnsABBV

AbbVie Stock Performance Indicators

Estimated Market Risk
  actual daily
 13 %
of total potential
Expected Return
  actual daily
 0 %
of total potential
Risk-Adjusted Return
  actual daily
 1 %
of total potential
Based on monthly moving average AbbVie is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AbbVie by adding it to a well-diversified portfolio.

AbbVie Alerts

Equity Alerts and Improvement Suggestions

Over 77.0% of the company shares are held by institutions such as insurance companies
On January 14, 2020 AbbVie paid $ 1.18 per share dividend to its current shareholders
Latest headline from newssmooth.com: Estimates could be Right AbbVie Inc., - NewsSmooth

AbbVie Dividends

AbbVie Dividends Analysis

Check AbbVie dividend payout schedule and payment analysis over time. Analyze past dividends calendar and estimate annual dividend income
Check Dividends  
Please continue to Trending Equities. Please also try Equity Search module to search for activelly-traded equities including funds and etfs from over 30 global markets.
Company logos by clearbit